VIS Credit Rating Company Limited (VIS) has reaffirmed the entity ratings of Macter International Limited (PSX: MACTER) at 'A' for medium-to-long term and 'A1' for short term, maintaining a 'Stable' outlook.
According to VIS, the ratings are supported by the company's conservative capital structure, stable earnings, and strong debt coverage metrics, backed by consistent demand in the pharmaceutical sector. Net sales for FY26 grew by 18.33% to Rs 11.7 billion, while gross margin improved to 48.25% from 44.69% in FY25 due to a better sales mix and growth in prescription and export segments.
| Financial Metric | FY25 | FY26 |
|---|---|---|
| Net Sales | - | Rs 11.7bn (+18.33%) |
| Gross Margin | 44.69% | 48.25% |
| Net Margin | 7.44% | 5.95% |
| Cash Conversion Cycle | 70 Days | 83 Days |
| Total Borrowings | - | Rs 1.04bn |
Investor Takeaway: Higher selling, distribution, and finance costs slightly moderated the net profit margin to 5.95%. However, strong debt coverage ratios (DSCR of 3.03x and FFO to total debt at 109%) reassure investors of the company's solid balance sheet strength.
Read the full story on the original publisher’s website.
Open original article